Use this resource - and many more! - in your textbook!
AcademicPub holds over eight million pieces of educational content for you to mix-and-match your way.
Not an educator but still interested in using this content? No problem! Visit our provider's page to contact the publisher and get permission directly.
Radiation internal dosimetry in radioimmunotherapy using 131I-rituximab
By: Jin Su Kim; Young Sub Lee; Sang Moo Lim; Hee-Joung Kim; Kyeong Min Kim;
2011 / IEEE / 978-1-4673-0120-6
Description
This item was taken from the IEEE Conference ' Radiation internal dosimetry in radioimmunotherapy using 131I-rituximab ' Radioimmunotherapy (RIT) is a promising approach for targeted therapy to treat intractable cancer because radionuclides are delivered more selective to tumor using monoclonal antibody, RIT can be used clinical practice with administration of murine anti-CD20. In this study, the absorbed dose of total body and red marrow of patient enrolled in RIT study was calculated.
Related Topics
Drugs
Radiation Therapy
Rit
Radiation Internal Dosimetry
131i-rituximab
Targeted Therapy
Intractable Cancer
Radionuclides
Tumor
Siemens Symbia T2 Spect/ct Scanner
Time-activity Curve
Whole-body Gamma Camera
Bi-exponential Function
Midose 3
Bone Marrow
Collimators
Time Measurement
Single Photon Emission Computed Tomography
Dosimetry
Cancer
Bone
Blood
Tumours
Engineering
Radioimmunotherapy
